TEBU-BIO ApS: Financial statements 2018
CVR: 10156920
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
TEBU-BIO ApS (CVR 10156920) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 654,861 and a net result of DKK 128,053 compared with DKK 8,972 the year before. That is an increase of 24.8% compared with the year before. Equity in the 2018 report amounted to DKK 280,064. The solvency ratio was 26.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 654,861
- Profit/Loss
- DKK 128,053
- Equity
- DKK 280,064
- Total Assets
- DKK 1,063,459
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 655 t. | 128 t. | 280 t. | 1 |
| 2017 | - | 525 t. | 9 t. | 152 t. | 1 |
| 2016 | - | 862 t. | 247 t. | 383 t. | 1 |
| 2015 | - | 979 t. | 375 t. | 511 t. | - |
| 2014 | - | 792 t. | 566 t. | 586 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
TEBU-BIO ApS has published its annual report for 2017. Gross profit came to DKK 524,738, and the net result was DKK 8,972.
About TEBU-BIO ApS
TEBU-BIO ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Donald van Dijk. The company is owned by Tebu bio S.A.. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,064,139 and a net result of DKK -414,038 compared with DKK -60,754 the year before. Equity in the 2025 report amounted to DKK -12,652.